The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database
- 242 Downloads
Previous studies assessing racial and ethnic differences in ovarian cancer (OVCA) diagnosis stage fail to present subtype-specific results and provide historic data on cases diagnosed between 10 and 20 years ago. The purpose of this analysis is to assess non-Hispanic Black (NHB) and non-Hispanic White (NHW) differences in late-stage diagnosis including; (1) factors associated with late-stage diagnosis of invasive epithelial OVCA overall and by histologic subtypes, (2) potential changes across time and (3) current patterns of trends in a national cancer registry in the USA and Puerto Rico between 1998 and 2011.
NHB and NHW OVCA cases were derived from the National Cancer Database (NCDB). Diagnosis stage was analyzed as a dichotomous and a four level-category variable, respectively; early (stages I and II; localized) versus late (stages III and IV; regional and distant) and stages I, II, III and IV. Diagnosis period was trichotomized (1998–2002, 2003–2007, 2008–2011). Racial differences in stage were tested using Chi-square statistics. Odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated using multivariable binomial and generalized ordered logistic regressions. Interactions between race and diagnosis period were evaluated.
Between 1998 and 2011, 11,562 (7.8 %) NHB and 137,106 (92.2 %) NHW were diagnosed with OVCA. In adjusted models, NHB were significantly more likely diagnosed with late-stage OVCA than NHW (ORadj 1.26, 95 % CI 1.19–1.33). Interaction between race and diagnosis period was marginally significant (p value = 0.09), with racial differences in stage decreasing over time (1998–2002: ORadj 1.36, 95 % CI 1.23–1.49; 2003–2007: ORadj 1.27, 95 % CI 1.15–1.39; 2008–2011; ORadj 1.15, 95 % CI 1.05–1.27). NHB were also more likely to be diagnosed with stage 4 high-grade serous (ORadj 1.46, 95 % CI 1.22–1.74), clear cell (ORadj 2.71, 95 % CI 1.94–3.79) and mucinous (ORadj 2.78, 95 % CI 2.24–3.46) carcinomas than NHW.
Racial differences in late-stage OVCA diagnosis exist; however, these differences are decreasing with time. Within NCDB, NHB are significantly more likely diagnosed with late-stage OVCA and more specifically high-grade serous, clear cell and mucinous carcinomas than NHW.
KeywordsOvarian cancer Racial differences Racial disparities Time-trend Diagnosis stage Non-Hispanic Black Non-Hispanic White High-grade serous
American Cancer Society Research Scholar Grant RSG-13-380-01-CPHPS. The CoC’s NCDB and the hospitals participating in the CoC NCDB are the source of the de-identified data used herein; they have not been verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.
A.B. Beckmeyer-Borowko: National Cancer Institute, National Institute of Health Grant NCI NIH R25CA057699. A.B. Beckmeyer-Borowko, C.E. Peterson, K.C. Brewer, M.A. Otoo, F.G. Davis, K.F. Hoskins, C.E. Joslin: American Cancer Society Research Scholar Grant RSG-13-380-01-CPHPS. C.E. Joslin: Departmental awards NIH/NEI EY01792 and Research to Prevent Blindness, Inc.
Compliance with ethical standards
Conflict of interest
The authors have no potential conflict of interest to disclose.
- 2.American Cancer Society (2015) Ovarian cancer. What are the key statistics about ovarian cancer? http://www.cancer.org/cancer/ovariancancer/detailedguide/ovarian-cancer-key-statistics. Accessed 12 Jan 2015
- 6.Alvarez RD, Karlan BY, Strauss JF (2016) Ovarian cancers: evolving paradigms in research and care. Report from the Institute of Medicine, Gynecologic oncologyGoogle Scholar
- 7.Braicu EI, Sehouli J, Richter R, Pietzner K, Denkert C, Fotopoulou C (2011) Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. Br J Cancer 105(12):1818–1824CrossRefPubMedPubMedCentralGoogle Scholar
- 9.National Cancer Institute (2015) SEER stat fact sheets: ovary cancer, surveillance, epidemiology, and end results. http://seer.cancer.gov/statfacts/html/ovary.html. Accessed 12 Jan 2015
- 10.Centers for Disease Control and Prevention (2014) CDC—ovarian cancer rates by race and ethnicity. Gynecologic Cancers. http://www.cdc.gov/cancer/ovarian/statistics/race.htm. Accessed 30 Nov 2015
- 16.American College of Surgeons (2016) National cancer data base. https://www.facs.org/quality-programs/cancer/ncdb. Accessed 12 Jan 2016
- 18.American College of Surgeons (2016) Patients demographics. National Cancer Database. http://ncdbpuf.facs.org/?q=taxonomy/term/105. Accessed 12 Jan 2016
- 28.National Healthcare Quality and Disparities Reports (2015) http://www.ahrq.gov/research/findings/nhqrdr/index.html. Accessed 13 Nov 2015
- 34.Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: The Public Health Disparities Geocoding Project. Am J Epidemiol 156(5):471–482CrossRefPubMedGoogle Scholar
- 39.NCI SEER Public-Use Data: Applications and Limitations in Oncology Research | Cancer Network, 18 Mar 2009. http://www.cancernetwork.com/oncology-journal/nci-seer-public-use-data-applications-and-limitations-oncology-research. Accessed 12 Jan 2016
- 40.Surveillance, Epidemiology, and End Results Program Turning Cancer Data Into Discovery, 18 Mar 2009. http://seer.cancer.gov/registries/terms.html. Accessed 24 Nov 2015
- 41.Frey WH (2010) New racial segregation measures for states and large metropolitan areas: analysis of the 2005–2009 American Community Survey. Brookings Institute, Washington, DCGoogle Scholar
- 42.Cancer Incidence-Surveillance, Epidemiology, and End Results (SEER) Registries Research Data. http://seer.cancer.gov/data/metadata.html
- 43.Number of Persons by Race and Hispanic Ethnicity for SEER Participants (2010) Census data, 18 Mar 2009. http://seer.cancer.gov/registries/data.html. Accessed 24 Nov 2015